Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PharmaCorp RxTSXV:PCRX -1.11%38 3-Year Share Buyback Ratio is -63.30 as of Jun. 2026. GuruFocus rates TSXV:PCRX with a GF Score™ of 38/100. The stock has 2 warning signs investors should review. Among 443 Healthcare Providers & Services companies, PharmaCorp Rx ranks worse than 94.13% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. PharmaCorp Rx's current 3-Year Share Buyback Ratio was -63.30%.
The historical rank and industry rank for PharmaCorp Rx's 3-Year Share Buyback Ratio or its related term are showing as below:
TSXV:PCRX'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -63.3 Med: -63.3 Max: -63.3
Current: -63.3
During the past 5 years, PharmaCorp Rx's highest 3-Year Share Buyback Ratio was -63.30%. The lowest was -63.30%. And the median was -63.30%.
TSXV:PCRX's 3-Year Share Buyback Ratio is ranked worse than 94.13% of 443
companies
in the Healthcare Providers & Services industry
Industry Median: -1.8
vs TSXV:PCRX: -63.30
PharmaCorp Rx (TSXV:PCRX) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
PharmaCorp Rx 3-Year Share Buyback Ratio Related Terms
PharmaCorp Rx 3-Year Share Buyback Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, PharmaCorp Rx's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmaCorp Rx 3-Year Share Buyback Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PharmaCorp Rx's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where PharmaCorp Rx's 3-Year Share Buyback Ratio falls into.
PharmaCorp Rx 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of -63.30 mean?
PharmaCorp Rx (TSXV:PCRX) has a 3-Year Share Buyback Ratio of -63.30 as of Jun. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for PharmaCorp Rx and its competitors. According to the industry distribution chart, PharmaCorp Rx ranks #417 out of 443 companies in the Healthcare Providers & Services industry, placing it in the top 94.1%.
Is PharmaCorp Rx's 3-Year Share Buyback Ratio too high?
PharmaCorp Rx's current 3-Year Share Buyback Ratio is -63.30. Based on the distribution chart, PharmaCorp Rx ranks #417 out of 443 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PharmaCorp Rx has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does PharmaCorp Rx's 3-Year Share Buyback Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, PharmaCorp Rx ranks #417 out of 443 companies for 3-Year Share Buyback Ratio. This places PharmaCorp Rx in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Healthcare Providers & Services company?
A good 3-Year Share Buyback Ratio depends on the Healthcare Providers & Services industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for PharmaCorp Rx and its competitors. PharmaCorp Rx's current 3-Year Share Buyback Ratio is -63.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCorp Rx stock overvalued right now?
PharmaCorp Rx (TSXV:PCRX) has a current 3-Year Share Buyback Ratio of -63.30. The current 3-Year Share Buyback Ratio is -63.30. PharmaCorp Rx's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For PharmaCorp Rx (TSXV:PCRX), the current 3-Year Share Buyback Ratio is -63.30 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PharmaCorp Rx Inc operates three PharmaChoice bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada-branded pharmacies as it come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The company will also acquire independently owned non-PharmaChoice Canada-bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner.
38GF Score
Get the complete analysis for TSXV:PCRX
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:PCRX has been successfully added to your 
